Skip to Content
Merck
CN
All Photos(1)

Documents

C3821

Sigma-Aldrich

Citrate-dextrose solution (ACD)

sterile-filtered

Sign Into View Organizational & Contract Pricing
All Photos(1)
Synonym(s):
Acid citrate-dextrose, Anticoagulant citrate-dextrose
CAS Number:
8013-89-6
MDL number:
MFCD00212913
UNSPSC Code:
12161700
NACRES:
NA.25

sterility

sterile-filtered

Quality Level

200

form

liquid

pH

4.5-5.5

storage temp.

2-8°C

Related Categories

General description

Citrate-dextrose solution (ACD) is an anticoagulant and preservative used routinely for blood storage. The ideal red blood cells shelf life is 21 days when stored in ACD solution. Red blood cells in ACD solution utilize glucose and their viability is impairs when reinfused.

Application

Citrate-dextrose solution (ACD) has been used for dilution of blood for haematological studies. It has also been used as an anticoagulant during blood collection by cardiac puncture from mice and human bone marrow isolation.
For research use only. Not for use in diagnostic procedures.

Biochem/physiol Actions

Useful for anticoagulation of whole blood; erythrocyte survival

related product

Product No.
Description
Pricing

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. Is Product C3821, Citrate-dextrose solution, also known as "ACD"?

    Yes. A synonym for this product is ACD, which stands for anticoagulant citrate dextrose.

  4. At what concentration should Product C3821, Citrate-dextrose solution, be used?

    Use 1 part citrate dextrose solution to 9 parts blood.

  5. What is the composition of Product C3821, Citrate-dextrose solution?

    The composition if this product is 22.0 g/L C3434 (Citric Acid, trisodium salt, dihydrate); 7.3 g/L C0759 (Citric Acid, anhydrous); and 24.5 g/L G7528 (D-(+)-Glucose).

  6. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  7. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  8. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study
Secunda R, et al.
Cytotechnology, 67(5), 793-807 (2015)
Mingming Yang et al.
Experimental and therapeutic medicine, 20(2), 1253-1260 (2020-08-09)
The p53 gene is well known as a key tumor suppressor gene; it is vital for hematopoietic stem cell differentiation and growth. In the present study, the change of platelets (PLTs) in p53 knockout mice (p53-/- mice) was investigated. The
The storage of hard-packed red blood cells in citrate-phosphate-dextrose (CPD) and CPD-adenine (CPDA-1)
Beutler E and West C
Blood, 54(1), 280-284 (1979)
Hideki Miyachi et al.
International journal of cardiology, 266, 61-66 (2018-06-12)
Acute thrombosis is a crucial cause of bioresorbable vascular graft (BVG) failure. Bone marrow-derived mononuclear cell (BM-MNC)-seeded BVGs demonstrated high graft patency, however, the effect of seeded BM-MNCs against thrombosis remains to be elucidated. Thus, we evaluated an antithrombotic effect
Comparison of equine platelet function and survival in whole blood collected in acid-citrate-dextrose solution or citrate-phosphate-dextrose-adenine solution
Bozorgmanesh R, et al.
Veterinary Clinical Pathology / American Society For Veterinary Clinical Pathology, 46(2), 262-268 (2017)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service